3.0.0 2668 2023-01-13T04:48:35Z 2023-01-13T04:48:35Z Senate S S 2006-04-27 109 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2006-04-27T19:43:27Z Reducing Fraudulent and Imitation Drugs Act of 2006 109 4829 HR 2006-03-17 Referred to the Subcommittee on Health. Identical bill CRS 2006-04-27 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2006-04-27 Introduced in Senate IntroReferral 10000 9 Library of Congress V000127 Sen. Vitter, David [R-LA] David Vitter R LA N Health Civil Rights and Liberties, Minority Issues Commerce Drug advertising Drug industry Drugs Fines (Penalties) Government Operations and Politics Government publicity Identification devices Intellectual property Labeling Law Packaging Product counterfeiting Right of privacy Science, Technology, Communications Health 00 2006-04-27 Introduced in Senate 2006-06-07T18:07:51Z Reducing Fraudulent and Imitation Drugs Act of 2006 - Directs the Secretary of Health and Human Services to require prescription drug packaging to incorporate: (1) radio frequency tagging technology or similar trace and track technologies; (2) tamper-indicating technologies; and (3) blister security packaging when possible.

Directs the Secretary to: (1) require that such technologies be used exclusively to authenticate the pedigree of prescription drugs; and (2) prohibit such technologies from containing or transmitting any identifying information of a health care practitioner or consumer, or any advertisement or information about indications or off-label uses.

Requires the Secretary to encourage prescription drug manufacturers and distributors to incorporate: (1) overt optically variable counterfeit-resistant technologies into packaging; and (2) required prescription drug packaging technologies into multiple elements of the physical packaging of the drugs. Requires prescription drug shipments to include a label on the shipping container that incorporates packaging technologies.

Deems a prescription drug to be misbranded if the packaging or labeling of the drug is in violation of a requirement or prohibition of this Act.

Requires the Secretary to publish the National Specified List of Susceptible Prescription Drugs, consisting of not less than 30 of the most frequently counterfeited prescription drugs in the United States.

]]> Reducing Fraudulent and Imitation Drugs Act of 2006 Display Title Reducing Fraudulent and Imitation Drugs Act of 2006 Official Title as Introduced A bill to direct the Secretary of Health and Human Services to require the incorporation of counterfeit-resistant technologies into the packaging of prescription drugs, and for other purposes. Introduced in Senate IS Short Titles as Introduced Reducing Fraudulent and Imitation Drugs Act of 2006 Introduced in Senate 2006-04-27T04:00:00Z 2006-04-27 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.